Prediction of bone loss in postmenopausal women
- PMID: 11193239
- DOI: 10.1007/s001980070005
Prediction of bone loss in postmenopausal women
Similar articles
-
Markers of bone turnover for the prediction of fracture risk.Osteoporos Int. 2000;11 Suppl 6:S55-65. doi: 10.1007/s001980070006. Osteoporos Int. 2000. PMID: 11193240 Review. No abstract available.
-
The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.Osteoporos Int. 2000;11 Suppl 6:S2-17. doi: 10.1007/s001980070002. Osteoporos Int. 2000. PMID: 11193237 Review. No abstract available.
-
The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.Osteoporos Int. 2017 Jan;28(1):211-218. doi: 10.1007/s00198-016-3692-6. Epub 2016 Jul 28. Osteoporos Int. 2017. PMID: 27468899
-
Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy.Osteoporos Int. 1995;5(4):276-80. doi: 10.1007/BF01774018. Osteoporos Int. 1995. PMID: 7492867 Clinical Trial.
-
Normal bone, osteoporosis and the rheumatologist.Rev Rhum Engl Ed. 1997 Jun 30;64(6 Suppl):3S-9S. Rev Rhum Engl Ed. 1997. PMID: 9273930 Review. No abstract available.
Cited by
-
Biochemical markers of bone turnover may predict progression to osteoporosis in osteopenic women: the JPOS Cohort Study.J Bone Miner Metab. 2007;25(2):122-9. doi: 10.1007/s00774-006-0736-6. Epub 2007 Feb 26. J Bone Miner Metab. 2007. PMID: 17323182
-
An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice.Eur J Clin Pharmacol. 2006 Oct;62(10):781-92. doi: 10.1007/s00228-006-0174-3. Epub 2006 Aug 16. Eur J Clin Pharmacol. 2006. PMID: 16912870 Review.
-
Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.Osteoporos Int. 2006;17(7):1086-95. doi: 10.1007/s00198-005-0052-3. Epub 2006 May 3. Osteoporos Int. 2006. PMID: 16758145
-
Background to and management of treatment-related bone loss in prostate cancer.Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002. Drugs Aging. 2002. PMID: 12495366 Review.
-
Bone Phenotyping Approaches in Human, Mice and Zebrafish - Expert Overview of the EU Cost Action GEMSTONE ("GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork").Front Endocrinol (Lausanne). 2021 Dec 1;12:720728. doi: 10.3389/fendo.2021.720728. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34925226 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources